and SOF III as of September '30. 2017 anti should be read and reviewed in conjunction with the "Impoltaii Infuf rnation" and Noteps to Per lormance Informatiori sections of this presentation. Peet perfonoart* is not a predicts of luttee returns and there can be no assurance that S0F IV will ecNeve comparable